Operator of a biopharmaceutical company in South Korea. TheThe company manufactures and distributes intravenous immunoglobulin (IVIG) and albumin products for the treatment of patients with infectious, immune diseases and burns.
What you see here scratches the surface
We’ll help you find what you need
This information is available in the PitchBook Platform. To explore GC Biotherapeutics‘s full profile, request access.
© 2021 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.